← All stocks

BRIGHT MINDS BIOSCIENCES INC.

DRUG Net selling
CIK 0001827401 #2754 in the set updated 19 Sep 2026
Bought (120 mo)
$7.23M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$9.79M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$9.79M
1 of 1 sales
Net
−$2.55M
−$2.55M against sales at will

By person

1 insider · 13 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Cormorant Asset Management, LP entity
Former 10% Owner
$7.23M (12)
$9.79M (1)
−$2.55M
950,000
21.00%
$85.03M
+110.0%
Insider
Date
Role
Action
Shares
Price
Amount
Cormorant Asset Management, LP
4 Nov 2024
10% owner
Buy indirect
184,331
$21.70
$4.00M
Cormorant Asset Management, LP
16 Oct 2024
10% owner
Buy indirect
3,107
$25.22
$78.36K
Cormorant Asset Management, LP
16 Oct 2024
10% owner
Buy indirect
7,150
$24.03
$171.81K
Cormorant Asset Management, LP
16 Oct 2024
10% owner
Buy indirect
39,743
$23.22
$922.63K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
4,609
$12.35
$56.93K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
19,169
$11.72
$224.60K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
2,700
$9.26
$25.01K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
2,600
$8.80
$22.89K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
8,900
$7.31
$65.02K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
33,343
$6.42
$214.22K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
63,173
$5.92
$374.24K
Cormorant Asset Management, LP
15 Oct 2024
10% owner
Buy indirect
238,097
$4.53
$1.08M

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 3
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 0
History held since 17 Oct 2024